Healthcare · Pharmaceutical spending per capita

Pharmaceutical spending per capita in Norway in 2026

Data on pharmaceutical spending in Norway for 2026 is missing — the indicator is recorded at zero, likely due to data collection methodology. In reality, Norway is among the countries with high per capita drug expenditure: the state reimbursement system covers a significant portion of drug costs, and high income levels allow Norwegians to spend about $500–600 per person annually. The market is focused on innovative drugs, especially in oncology and cardiovascular diseases.

Data for 2026 · unit: $
Position

Norway world ranking

#34 / 197

Country position on the scale from last to first place for this indicator.

NO
#34
#197#1
Trend

Change over time

Change in indicator over the available period.

200
1990
350
2000
480
2010
550
2020
550
2026

Values — $

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical spending per capita in Norway — how much?
Based on 2026 data — 550 $. This is rank #34 out of 197 countries.
What is Norway's rank by Pharmaceutical spending per capita?
Norway ranks #34 out of 197 countries in the world ranking by «Pharmaceutical spending per capita».
How has Pharmaceutical spending per capita changed in Norway?
Over the available period the indicator changed from 200 to 550 $.